Designing a chimeric subunit vaccine for influenza virus, based on HA2, M2e and CTxB: a bioinformatics study

Abstract Background Type A influenza viruses are contagious and even life-threatening if left untreated. So far, no broadly protective vaccine is available due to rapid antigenic changes and emergence of new subtypes of influenza virus. In this study, we exploited bioinformatics tools in order to de...

Full description

Bibliographic Details
Main Authors: Davod Jafari, Sara Malih, Mohammad Mahmoudi Gomari, Marzieh Safari, Rasool Jafari, Mohammad Morad Farajollahi
Format: Article
Language:English
Published: BMC 2020-12-01
Series:BMC Molecular and Cell Biology
Subjects:
Online Access:https://doi.org/10.1186/s12860-020-00334-6
_version_ 1818432776865579008
author Davod Jafari
Sara Malih
Mohammad Mahmoudi Gomari
Marzieh Safari
Rasool Jafari
Mohammad Morad Farajollahi
author_facet Davod Jafari
Sara Malih
Mohammad Mahmoudi Gomari
Marzieh Safari
Rasool Jafari
Mohammad Morad Farajollahi
author_sort Davod Jafari
collection DOAJ
description Abstract Background Type A influenza viruses are contagious and even life-threatening if left untreated. So far, no broadly protective vaccine is available due to rapid antigenic changes and emergence of new subtypes of influenza virus. In this study, we exploited bioinformatics tools in order to design a subunit chimeric vaccine from the antigenic and highly conserved regions of HA and M2 proteins of H7N9 subtype of influenza virus. We used mucosal adjuvant candidates, including CTxB, STxB, ASP-1, and LTB to stimulate mucosal immunity and analyzed the combination of HA2, M2e, and the adjuvant. Furthermore, to improve the antigen function and to maintain their three-dimensional structure, 12 different linkers including six rigid linkers and six flexible linkers were used. The 3D structure model was generated using a combination of homology and ab initio modeling methods and the molecular dynamics of the model were analyzed, either. Results Analysis of different adjuvants showed that using CtxB as an adjuvant, results in higher overall vaccine stability and higher half-life among four adjuvant candidates. Fusion of antigens and the CTxB in the form of M2e-linker-CTxB-linker-HA2 has the most stability and half life compared to other combination forms. Furthermore, the KPKPKP rigid linker showed the best result for this candidate vaccine among 12 analyzed linkers. The changes in the vaccine 3D structure made by linker insertion found to be negligible, however, although small, the linker insertion between the antigens causes the structure to change slightly. Eventually, using predictive tools such as Ellipro, NetMHCpan I and II, CD4episcore, CTLpred, BepiPred and other epitope analyzing tools, we analyzed the conformational and linear epitopes of the vaccine. The solubility, proteasome cleavage sites, peptidase and potential chemical cutters, codon optimization, post translational modification were also carried out on the final vaccine. Conclusions It is concluded that M2e-Linker-CTxB-Linker-HA2 combination of chimeric vaccine retains its 3D structure and antigenicity when KPKPKP used as linker and CTxB used as adjuvant.
first_indexed 2024-12-14T16:10:35Z
format Article
id doaj.art-71e64e7e0db14378a62034ef28b4bf26
institution Directory Open Access Journal
issn 2661-8850
language English
last_indexed 2024-12-14T16:10:35Z
publishDate 2020-12-01
publisher BMC
record_format Article
series BMC Molecular and Cell Biology
spelling doaj.art-71e64e7e0db14378a62034ef28b4bf262022-12-21T22:55:01ZengBMCBMC Molecular and Cell Biology2661-88502020-12-0121111310.1186/s12860-020-00334-6Designing a chimeric subunit vaccine for influenza virus, based on HA2, M2e and CTxB: a bioinformatics studyDavod Jafari0Sara Malih1Mohammad Mahmoudi Gomari2Marzieh Safari3Rasool Jafari4Mohammad Morad Farajollahi5Student Research Committee, Faculty of Allied Medicine, Iran University of Medical SciencesDepartment of Medical Biotechnology, Faculty of Medical Sciences, Tarbiat Modares UniversityDepartment of Medical Biotechnology, Faculty of Allied Medicine, Iran University of Medical SciencesDepartment of Microbiology, Faculty of Medicine, Isfahan University of Medical SciencesDepartment of Medical Parasitology and Mycology, Faculty of Medicine, Urmia University of Medical SciencesStudent Research Committee, Faculty of Allied Medicine, Iran University of Medical SciencesAbstract Background Type A influenza viruses are contagious and even life-threatening if left untreated. So far, no broadly protective vaccine is available due to rapid antigenic changes and emergence of new subtypes of influenza virus. In this study, we exploited bioinformatics tools in order to design a subunit chimeric vaccine from the antigenic and highly conserved regions of HA and M2 proteins of H7N9 subtype of influenza virus. We used mucosal adjuvant candidates, including CTxB, STxB, ASP-1, and LTB to stimulate mucosal immunity and analyzed the combination of HA2, M2e, and the adjuvant. Furthermore, to improve the antigen function and to maintain their three-dimensional structure, 12 different linkers including six rigid linkers and six flexible linkers were used. The 3D structure model was generated using a combination of homology and ab initio modeling methods and the molecular dynamics of the model were analyzed, either. Results Analysis of different adjuvants showed that using CtxB as an adjuvant, results in higher overall vaccine stability and higher half-life among four adjuvant candidates. Fusion of antigens and the CTxB in the form of M2e-linker-CTxB-linker-HA2 has the most stability and half life compared to other combination forms. Furthermore, the KPKPKP rigid linker showed the best result for this candidate vaccine among 12 analyzed linkers. The changes in the vaccine 3D structure made by linker insertion found to be negligible, however, although small, the linker insertion between the antigens causes the structure to change slightly. Eventually, using predictive tools such as Ellipro, NetMHCpan I and II, CD4episcore, CTLpred, BepiPred and other epitope analyzing tools, we analyzed the conformational and linear epitopes of the vaccine. The solubility, proteasome cleavage sites, peptidase and potential chemical cutters, codon optimization, post translational modification were also carried out on the final vaccine. Conclusions It is concluded that M2e-Linker-CTxB-Linker-HA2 combination of chimeric vaccine retains its 3D structure and antigenicity when KPKPKP used as linker and CTxB used as adjuvant.https://doi.org/10.1186/s12860-020-00334-6AdjuvantBioinformaticsEpitopesHemagluttininInfluenza a virusVaccine design
spellingShingle Davod Jafari
Sara Malih
Mohammad Mahmoudi Gomari
Marzieh Safari
Rasool Jafari
Mohammad Morad Farajollahi
Designing a chimeric subunit vaccine for influenza virus, based on HA2, M2e and CTxB: a bioinformatics study
BMC Molecular and Cell Biology
Adjuvant
Bioinformatics
Epitopes
Hemagluttinin
Influenza a virus
Vaccine design
title Designing a chimeric subunit vaccine for influenza virus, based on HA2, M2e and CTxB: a bioinformatics study
title_full Designing a chimeric subunit vaccine for influenza virus, based on HA2, M2e and CTxB: a bioinformatics study
title_fullStr Designing a chimeric subunit vaccine for influenza virus, based on HA2, M2e and CTxB: a bioinformatics study
title_full_unstemmed Designing a chimeric subunit vaccine for influenza virus, based on HA2, M2e and CTxB: a bioinformatics study
title_short Designing a chimeric subunit vaccine for influenza virus, based on HA2, M2e and CTxB: a bioinformatics study
title_sort designing a chimeric subunit vaccine for influenza virus based on ha2 m2e and ctxb a bioinformatics study
topic Adjuvant
Bioinformatics
Epitopes
Hemagluttinin
Influenza a virus
Vaccine design
url https://doi.org/10.1186/s12860-020-00334-6
work_keys_str_mv AT davodjafari designingachimericsubunitvaccineforinfluenzavirusbasedonha2m2eandctxbabioinformaticsstudy
AT saramalih designingachimericsubunitvaccineforinfluenzavirusbasedonha2m2eandctxbabioinformaticsstudy
AT mohammadmahmoudigomari designingachimericsubunitvaccineforinfluenzavirusbasedonha2m2eandctxbabioinformaticsstudy
AT marziehsafari designingachimericsubunitvaccineforinfluenzavirusbasedonha2m2eandctxbabioinformaticsstudy
AT rasooljafari designingachimericsubunitvaccineforinfluenzavirusbasedonha2m2eandctxbabioinformaticsstudy
AT mohammadmoradfarajollahi designingachimericsubunitvaccineforinfluenzavirusbasedonha2m2eandctxbabioinformaticsstudy